Our Blog
See below for an opinion on current matters around the world.
The Good, the Bad, and the Ugly: Australia’s HTA Review Final Report
Is the new price right?: HTA takes a back seat to broader price negotiations
Could Human HTA Committees be Replaced with AI Systems?
Ghosts in the Machine: the search for productivity measures in health technology assessment
Land of the Long Wait Crowd: problems in New Zealand's medicine funding system
Pharmaceuticals Take Centre Stage in Australian Election Campaign
Jane Fonda, mix tapes & Australia's 5% discount rate: when time, health economics and ethics collide
NICE methods review, UK Life Sciences Strategy and the life sciences industry: lessons for Australia
HTA 2.0: time for a reboot
Universal health coverage and health technology assessment in Sub-Saharan Africa
Martians, ministers and medicines funding: the budget impact problem